K

Pasithea Therapeutics Corp
D

KTTA

1.31000
USD
-0.05
(-3.68%)
مغلق
حجم التداول
422
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
1,659,019
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Pasithea Therapeutics Corp

القطاع: Healthcare
الصناعة: Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.